Literature DB >> 30566054

The Cardiac Myofibroblast.

Michael Alexanian1, Saptarsi M Haldar1,2.   

Abstract

Entities:  

Keywords:  Editorials; cardiomyopathies; fibrosis; heart failure; myofibroblast

Mesh：

Substances：

Year:  2018        PMID： 30566054      PMCID： PMC6453134          DOI： 10.1161/CIRCRESAHA.118.314185

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  The long noncoding RNA Wisper controls cardiac fibrosis and remodeling.

Authors:  Rudi Micheletti; Isabelle Plaisance; Brian J Abraham; Alexandre Sarre; Ching-Chia Ting; Michael Alexanian; Daniel Maric; Damien Maison; Mohamed Nemir; Richard A Young; Blanche Schroen; Arantxa González; Samir Ounzain; Thierry Pedrazzini
Journal:  Sci Transl Med       Date:  2017-06-21       Impact factor: 17.956

Review 2.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

3.  Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy.

Authors:  Qinghang Meng; Bidur Bhandary; Md Shenuarin Bhuiyan; Jeanne James; Hanna Osinska; Iñigo Valiente-Alandi; Kritton Shay-Winkler; James Gulick; Jeffery D Molkentin; Burns C Blaxall; Jeffrey Robbins
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

4.  An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure.

Authors:  Md Abdur Razzaque; Manish Gupta; Hanna Osinska; James Gulick; Burns C Blaxall; Jeffrey Robbins
Journal:  Circ Res       Date:  2013-07-12       Impact factor: 17.367

5.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

6.  Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.

Authors:  Sakthivel Sadayappan; James Gulick; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffery D Molkentin; Jeffrey Robbins
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

7.  Cardiac myosin binding protein C phosphorylation is cardioprotective.

Authors:  Sakthivel Sadayappan; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffrey D Molkentin; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.

Authors:  Hadi Khalil; Onur Kanisicak; Vikram Prasad; Robert N Correll; Xing Fu; Tobias Schips; Ronald J Vagnozzi; Ruijie Liu; Thanh Huynh; Se-Jin Lee; Jason Karch; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2017-09-11       Impact factor: 14.808

Review 9.  Genetics of hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Stephen Chang; Jonathan G Seidman; Christine E Seidman
Journal:  Curr Opin Cardiol       Date:  2010-05       Impact factor: 2.161

10.  Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.

Authors:  Xing Fu; Hadi Khalil; Onur Kanisicak; Justin G Boyer; Ronald J Vagnozzi; Bryan D Maliken; Michelle A Sargent; Vikram Prasad; Iñigo Valiente-Alandi; Burns C Blaxall; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808
View more
  2 in total

1.  Epigenetic therapies in heart failure.

Authors:  Michael Alexanian; Arun Padmanabhan; Timothy A McKinsey; Saptarsi M Haldar
Journal:  J Mol Cell Cardiol       Date:  2019-04-13       Impact factor: 5.000

2.  Stimulation of Sigma-1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment.

Authors:  Jing Qu; Miaoling Li; Dongxu Li; Yanguo Xin; Junli Li; Song Lei; Wenchao Wu; Xiaojing Liu
Journal:  Oxid Med Cell Longev       Date:  2021-01-04       Impact factor: 6.543
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.